Nexstim Receives an
Nexstim Receives an NBS System Upgrade Order from a Finnish Hospital
December 29, 2021 02:30 ET | Nexstim Oyj
Press release, Helsinki, 29 December 2021 at 9:30 AM (EET) Nexstim Receives an NBS System Upgrade Order from a Finnish Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") has...
Nexstim Receives an
Nexstim Receives an NBS System Order from a Hospital in Germany
December 08, 2021 04:30 ET | Nexstim Oyj
Press release, Helsinki, December 8, 2021 at 11:30 AM (EET) Nexstim Receives an NBS System Order from a Hospital in Germany Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces...
Nexstim har kommit ö
Nexstim har kommit överens om en strategisk investering i en Management Services-organisation för en Kalifornien-baserad klinik som tillhandahåller behandlingar för depressionspatienter
November 22, 2021 02:00 ET | Nexstim Oyj
Företagsmeddelande, insiderinformation, Helsingfors, 22.11.2021 kl. 9.00 (EET) Nexstim har kommit överens om en strategisk investering i en Management Services-organisation för en Kalifornien-baserad...
Nexstim on sopinut s
Nexstim on sopinut strategisesta investoinnista masennuspotilaille hoitoja tarjoavaan kalifornialaisen klinikan palveluyhtiöön
November 22, 2021 02:00 ET | Nexstim Oyj
Yhtiötiedote, sisäpiiritieto, Helsinki, 22.11.2021 klo 9.00 (EET) Nexstim on sopinut strategisesta investoinnista masennuspotilaille hoitoja tarjoavaan kalifornialaisen klinikan palveluyhtiöön ...
Nexstim Agrees on a
Nexstim Agrees on a Strategic Investment into a Management Services Organisation of a California Based Clinic Providing Treatments for Depression Patients
November 22, 2021 02:00 ET | Nexstim Oyj
Company Announcement, Inside information, Helsinki, 22.11.2021 at 9 AM (EET) Nexstim Agrees on a Strategic Investment into a Management Services Organisation of a California Based Clinic Providing...
Nexstim Releases the
Nexstim Releases the New NBS5+ in the United States
October 22, 2021 02:00 ET | Nexstim Oyj
Press release, Helsinki, 22 October 2021 at 9 AM (EEST) Nexstim Releases the New NBS5+ in the United States Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the launch of a new...
Nexstim’s SmartFocus
Nexstim’s SmartFocus® TMS Technology Used in Award-Winning Project Addressing Disorders of Consciousness after Severe Brain Injury
October 15, 2021 02:00 ET | Nexstim Oyj
Press release, Helsinki, 15 October 2021 at 9 AM (EEST) Nexstim’s SmartFocus® TMS Technology Used in Award-Winning Project Addressing Disorders of Consciousness after Severe Brain Injury Nexstim Plc...
Featured Image for Actipulse Neuroscience
Actipulse Neuroscience Announces Successful Clinical Trial Using Fast Gamma Magnetic Stimulation for the Treatment of Alzheimer's Disease
September 30, 2021 15:00 ET | Actipulse Neuroscience
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Today, the results of a recent pilot clinical trial, funded by neurotech company Actipulse Neuroscience, have demonstrated that its non-invasive...
Nexstim Receives Sys
Nexstim Receives System Orders from Existing Hospital Customers in Finland
September 15, 2021 02:00 ET | Nexstim Oyj
Press release, Helsinki, 15 September 2021 at 9 AM (EEST) Nexstim Receives System Orders from Existing Hospital Customers in Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company")...
Nexstim Reaches 208
Nexstim Reaches 208 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry
August 20, 2021 02:00 ET | Nexstim Oyj
Press release, Helsinki, 20 August 2021 at 9 AM (EEST) Nexstim Reaches 208 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry...